Dose-dependent relationship between SGLT2 inhibitor hold time and risk for postoperative anion gap acidosis. Response to Br J Anaesth 2023; 131: 682-686. Br J Anaesth 2024; 132: 822-3

Br J Anaesth. 2024 May;132(5):993-994. doi: 10.1016/j.bja.2024.01.041. Epub 2024 Mar 5.

Author

Benjamin Steinhorn¹

Affiliation

¹ Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA. Electronic address: bsteinhorn@mgh.harvard.edu.

PMID: 38448270
DOI: 10.1016/j.bja.2024.01.041

No abstract available

Keywords: SGLT2 inhibitor; diabetes mellitus; diabetic ketoacidosis; euglycaemic diabetic ketoacidosis; metabolic acidosis; patient safety.

Publication types

Letter

MeSH terms

Acid-Base Equilibrium
Acidosis*
Diabetes Mellitus, Type 2*
Diabetic Ketoacidosis*
Humans
Sodium-Glucose Transporter 2 Inhibitors* / adverse effects

Substances

Sodium-Glucose Transporter 2 Inhibitors